Memo Therapeutics raised CHF 20 million in Series C extension funding from investors including Ysios Capital and Kurma Partners.

Biotech Health services Manufacturing

Investments

01 May 2024

Memo Therapeutics (company)

Biotech Health services Manufacturing

Total investments received (USD): 112.24m

Round value (USD): 21.98m

Round investors: Kurma Life Science Partners Ysios Capital

Industry: Biotech Health services Manufacturing

Biotech Health services Pharma

Investments 03 September 2024

Health services Manufacturing Robotics

Investments 24 December 2023

Biotech Health services Manufacturing

Investments 24 December 2023

Biotech Health services Manufacturing Pharma

Investments 15 December 2023

Agriculture Biotech Energy Manufacturing Social Responsibility

Investments 06 December 2023